Science Explorer Back to mapMap
Discussion
Researcher · Kyushu Economic Research Center · Japan

Takayuki Shimose

Takayuki Shimose publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies and Lung Cancer Research Studies.

OpenAlex
World rank
#4,898,312
of 7,710,434 ranked researchers
Rank in Japan
#151,606
of 383,136
Works
47
Citations
474
Citations per work
10.1
h-index
11
i10-index 12Top 46% in Pulmonary and Respiratory Medicine
Takayuki Shimose

What does Takayuki Shimose research?

Takayuki Shimose's work is mostly in Medicine (68%), Biochemistry, Genetics and Molecular Biology (6%).

Health Sciences: 32 works · 68.4% of their workMedicine: 32 works · 68.4% of their workPulmonary and Respiratory Medicine: 14 works · 29.2% of their workOncology: 12 works · 26.2% of their workGenetics: 3 works · 5.4% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 3.8% of their workRheumatology: 2 works · 3.8% of their workEverything else: 12 works · 25.4% of their workLife Sciences: 3 works · 6.2% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 6.2% of their workMolecular Biology: 3 works · 6.2% of their workTHEIR WORKTakayuki Shimose47works
Life Sciences6%Health Sciences68%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3268.4%
  2. Everything else1225.4%
    1. Biochemistry, Genetics and Molecular Biology36.2%
  1. 1Pulmonary and Respiratory Medicine29% of their works
  2. 2Oncology26% of their works
  3. 3Molecular Biology6% of their works
  4. 4Genetics5% of their works
  5. 5Rheumatology4% of their works
  6. 6Radiology, Nuclear Medicine and Imaging4% of their works

Research topics

Which keywords describe Takayuki Shimose's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, ALK Inhibitors, EGFR Mutations, Prognostic Factors, Cetuximab and KRAS Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Targeted Therapy333 topics
  2. Clinical Trials292 topics
  3. Chemotherapy253 topics
  4. ALK Inhibitors221 topic
  5. EGFR Mutations221 topic
  6. Prognostic Factors132 topics
  7. Cetuximab111 topic
  8. KRAS Mutations111 topic
  9. CT Screening71 topic
  10. Genomic Profiles71 topic
  11. Lung Cancer71 topic
  12. Small-Cell Lung Cancer71 topic
  13. Chronic Lymphocytic Leukemia61 topic
  14. Genomic Aberrations61 topic
  15. Immune Checkpoint Blockade61 topic
  16. PD-1 and PD-L161 topic
  17. Cancer Cachexia41 topic
  18. Cancer Genomics41 topic
  19. Mutational Signatures41 topic
  20. Sarcopenia41 topic

Where does Takayuki Shimose work?

Takayuki Shimose's main affiliation in the publication record is Kyushu Economic Research Center, Japan.

How many publications and citations does Takayuki Shimose have?

OpenAlex counts 47 works and 474 citations for Takayuki Shimose, an h-index of 11, ranking #4,898,312 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Takayuki Shimose. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.